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Background: Individuals with most forms of mental illness have higher rates of obesity than 
members of the general public putting them at an increased risk for many physical health 
problems that reduce both quality of life and life expectancy. The presence of multiple comorbid 
psychiatric disorders has been associated with poorer clinical outcomes in other mental health 
measures such as disability and sobriety and is proposed as a risk factor for elevated BMI (body 
mass index) in this study. 
Objective: Determine if multiple psychiatric comorbidities are associated with elevated BMI and, 
if so, which combinations are linked with the greatest risk. 
Design: A secondary analysis of the Collaborative Psychiatric Epidemiology Surveys dataset. The 
psychiatric disorder group (N=7,355) included individuals reporting symptoms of one or more 
mental illnesses. Controls (N=12,658) included subjects reporting no symptoms suggesting the 
presence of a psychiatric disorder. BMI was examined using descriptive statistics, t-tests, and 
Chi-square analyses. 
Results: The number of comorbid psychiatric disorders an individual had was associated with 
BMI. In particular, bipolar disorder, agoraphobia, panic disorder, and attention-deficit 
hyperactivity (ADHD) disorder had the greatest number of association and the largest effect sizes. 
Conclusion: Medical professionals should monitor patients more closely for weight gain when 
they have multiple psychiatric disorders. Patients with bipolar disorder, agoraphobia, panic 
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Obesity has been associated with an increased risk for stroke, heart disease, arthritis, 
diabetes, asthma, chronic back pain, and most forms of cancer (Guh et al., 2009). All of these 
physical problems reduce quality of life and many of them shorten life expectancy (Kolotkin et 
al., 2008; Manuel, Schultz, & Kopec, 2002). Among high-income countries, overweight and 
obesity has been estimated to account for 7.8% of deaths and 7.2% of disability adjusted life 
years (Lopez & Mathers, 2006). The direct medical costs of elevated BMI (body mass index) in 
the United States has been estimated to be almost $114 billion, accounting for up to 10% of 
healthcare spending (Tsai, Williamson, & Glick, 2011). 
 Individuals with a wide variety of psychiatric disorders have been shown to have higher 
rates of obesity than members of the general public. A meta-analysis found that the presence of 
depression was associated with a 1.58 times increased risk of developing obesity over individuals 
without depression (Luppino et al., 2010). A meta-analysis of cross-sectional studies found that 
individuals with anxiety disorders were at a 1.4 times greater risk for obesity (Gariepy, Nitka, & 
Schmitz, 2010). Researchers have found people with schizophrenia and bipolar disorder are at a 
3.4 times and 1.7 times higher risk for obesity (Gurpegui et al., 2012; Petry, Barry, Pietrzak, & 
Wagner, 2008). 
 Despite the higher prevalence of obesity among individuals with mental illness, a 
Cochrane Review of cognitive, behavioral, and pharmacological weight loss programs in this 
population found that interventions are associated with small effect sizes and a short duration of 
impact (Faulkner, Cohn, & Remington, 2009). As a result, the prevention of obesity among 
individuals with psychiatric problems may hold greater promise than weight loss programs. 
However, the widespread use of preventative interventions can be costly and may expose 
individuals at low risk for gaining weight to potential adverse effects. For example, the use of 
medication to help with appetite control may expose some individuals to side effects or allergic 
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reactions. As a result, it is essential to explore early risk factors for the development of obesity in 
order to identify individuals who require the most intensive interventions.  
 A variety of explanations have been proposed for the increased rates of obesity seen 
among individuals with mental illness. It is likely that some secondary factors associated with 
mental illness, such as socioeconomic status, play a role in this phenomenon (Guenzel, 2015). 
However, it is also logical to deduce that some symptoms of the psychiatric disorders themselves 
are at fault such as alterations in neurological reward pathways and increased appetite (Grimm, 
Vollstädt-Klein, Krebs, Zink, & Smolka, 2012). Little research has been conducted to examine 
these relationships, but a number of mechanisms have been proposed. For example, among 
individuals with attention-deficit hyperactivity disorder (ADHD), it has been hypothesized that 
binge eating behaviors and food as a form of self-medication contribute to weight gain (Davis, 
2010). 
 Research has examined some effects of comorbid psychiatric disorders. Specifically, one 
systematic review found that anxiety comorbid with schizophrenia was associated with increased 
symptoms and poorer outcomes (Braga, Reynolds, & Siris, 2013). Another study found that 
individuals who had anxiety or depression in addition to an alcohol use disorder were more 
disabled and drank more after treatment than those without anxiety or depression (Burns, 
Teesson, & O'Neill, 2005). 
 The researchers hypothesize that the presence of multiple psychiatric disorders may be 
associated with higher rates of obesity. Based on previous research regarding associations 
between the symptoms of various forms of mental illness and obesity, there is reason to infer that 
the effects of multiple comorbid psychiatric disorders may compound to result in an even greater 
risk for elevated BMI. For example, if an individual has the altered reward pathways associated 
with schizophrenia in addition to the binge eating behaviors sometimes seen with ADHD we can 
see how his or her risk of weight gain may be higher than if he or she had either disorder alone. 
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Once specific combinations of disorders that lead to the greatest risk of obesity are identified, 
practitioners can use this information in screening and offering more intensive weight 
management interventions. The purpose of this article is determine if the presence of multiple 
psychiatric comorbidities is associated with elevated BMI. 
Conceptual Model 
 The conceptual model developed for this article is based on the hypothesis that the 
presence of multiple comorbid psychiatric disorders increases the risk for obesity (see Appendix 
A). This model proposes that multiple psychiatric disorders are associated with an elevated 
symptom burden. No consensus exists regarding the definition of symptom burden in mental 
health, but for the purposes of this model, symptom burden has been defined as an increased 
number, intensity, frequency and/or duration of psychiatric symptoms. It is inferred that an 
elevated symptom burden often leads to increased numbers and doses of medications, lower 
socioeconomic status, more numerous and severe health problems, physical inactivity, and poorer 
dietary habits. These factors then increase an individual's risk for developing obesity. 
 A number of interrelationships are possible within this model. Specifically, obesity can 
lead to reduced SES, health problems, physical inactivity, and a poor diet (Baum & Ford, 2004; 
Guh et al., 2009; Tucker, Tucker, LeCheminant, & Bailey, 2013). Higher levels of many 
psychiatric medications can lead to health problems and poor dietary patterns (Cuerda, Velasco, 
Merchán-Naranjo, García-Peris, & Arango, 2014; Limosin, Gasquet, Leguay, Azorin, & 
Rouillon, 2008; McIntyre, 2009). Low SES is often associated with health problems, physical 
inactivity, and poor dietary patterns (Gordon-Larsen, Nelson, Page, & Popkin, 2006; Kanjilal et 
al., 2006; Wang & Chen, 2011). Health problems can lead to physical inactivity and vice-versa 
(Lee et al., 2012; Sokka et al., 2008). It has also been well documented that poor dietary habits 
can lead to a wide variety of health problems (Jakobsen et al., 2009; Malik et al., 2010). Lastly, 
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low SES, health problems, physical inactivity, and poor diet can all lead to elevated symptom 
burden (Jacka et al., 2010; Luppino et al., 2010; Ströhle, 2009). 
Aims 
The model is designed to test the three specific aims of this study: 
1. Determine if more than one psychiatric comorbidities is associated with elevated BMI. 
It is hypothesized that subjects with multiple mental health conditions will have a higher BMI 
than those without any psychiatric disorders. 
2. Identify which comorbid mental health conditions are most strongly associated with an 
increased risk for elevated BMI. 
It is hypothesized that some psychiatric disorders will be associated with a greater risk of elevated 
BMI than others. 
3. Determine if the number of psychiatric disorders is associated with elevated BMI. 
It is hypothesized that as the number of psychiatric disorders increases BMI will increase also. 
Methods and Procedure 
 This study was conducted as a secondary analysis of the Collaborative Psychiatric 
Epidemiology Surveys (CPES) dataset using a descriptive case-control design.  
Sample 
 The CPES dataset contains information on 20,013 community-dwelling individuals over 
the age of 18. Participants were selected with the use of multi-stage randomized sampling in 252 
geographic areas across the United States (Alegria, Jackson, Kessler, & Takeuchi, 2009). The 
weighted randomization procedure produced a sample which likely represents community-
dwelling adults in the United States who would report having symptoms of the various disorders 
in a clinical interview (Heeringa et al., 2004). 
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The CPES dataset was comprised of three survey interviews conducted between 2001 and 
2003 (Alegria, Jackson, Kessler, & Takeuchi, 2009). Interviews were conducted in participants’ 
homes by lay personnel using a computer program. The data was collected based on self-report 
and then combined into a single dataset. Personal identifying information was removed for the 
publically-available dataset and this version was sufficient for the current study. 
The CPES was based on the Composite International Diagnostic Interview (CIDI). The 
CIDI was developed for the World Mental Health Survey Initiative and has been used since the 
1990s (Wittchen, 1994). The structured interview was intended for use in the field by lay 
individuals to produce diagnoses based on the World Health Organization’s International 
Classification of Disease Criteria and the American Psychiatric Association’s Diagnostic and 
Statistical Manual (Alegria, Jackson, Kessler, & Takeuchi, 2009). Studies examining the CIDI 
have found that its use by lay individuals produces diagnoses similar to those identified by 
clinicians using semi-structured interviews. In addition, researchers have shown the CIDI to have 
a concordance rate of 0.76 with the Structured Clinical Interview for the DSM-IV (Haro et al., 
2006). 
Furthermore, studies have shown that the CIDI has higher test-retest reliability than semi-
structured interviews conducted by clinicians (Kendler, Gallagher, Abelson, & Kessler, 
1996).The CIDI asks respondents a large number of questions about symptoms of all the major 
forms of mental illness. Based on the responses, the CIDI produces probable diagnoses. The 
disorders identified by the CIDI include major depression, bipolar disorder, alcohol use disorders 
(alcohol abuse or alcohol dependence), drug use disorders (drug abuse or drug dependence), 
conduct disorder, intermittent explosive disorder, oppositional defiant disorder, attention deficit 
hyperactivity disorder, generalized anxiety disorder, panic disorder, separation anxiety, social 
phobia, agoraphobia, specific phobia, and post-traumatic stress disorder. 
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The CIDI does not identify participants who likely have schizophrenia. The survey did, 
however, elicit information on specific positive and negative symptoms in addition to psychiatric 
history. For this study, individuals who reported positive and negative symptoms consistent with 
a diagnosis of schizophrenia were included as having this disorder. In addition, participants who 
reported ever having been diagnosed with or disabled by schizophrenia were regarded as having 
the condition. 
Measures 
 The current study included all participants who reported symptoms consistent with a 
diagnosis of schizophrenia, major depressive disorder, bipolar disorder, alcohol use disorders, 
drug use disorders, conduct disorder, intermittent explosive disorder, oppositional defiant 
disorder, attention deficit hyperactivity disorder, generalized anxiety disorder, panic disorder, 
separation anxiety, social phobia, agoraphobia, specific phobia, and post-traumatic stress 
disorder. Participants who reported symptoms consistent with DSM-IV criteria for the disorders 
listed previously were included in the respective mental illness groups. Participants who reported 
having symptoms consistent with any of the disorders listed above were included in the control 
group. 
 Subject-reported height and weight were used to calculate body mass index (BMI) 
according to the following formula: weight in kilograms / (height in meters)2 (Alegria et al., 
2009). Research has found that men tend to overestimate their height and weight whereas women 
overestimate their height and underestimate their weight (Merrill & Richardson, 2009). However, 
the same study found that men underestimated their BMI by only 0.34 units while women 
overestimated their BMI by 0.82 units. Errors of this size are not likely to skew the overall 
patterns of results within this study. Furthermore, we have no reason to believe that the accuracy 
of self-reported height and weight varies between individuals with mental illness and those 
without mental illness. 




The statistical analyses were performed using SPSS 23 (IBM Corp., 2015). The effect 
size of each t-test was calculated using the mean and standard deviation in a frequently used 
online tool (Becker, 1999). In addition, the power of most analyses was calculated using G-Power 
3.0.10 (Faul, Erdfelder, Lang, & Buchner, 2007). Results were considered significant at a p-value 
of less than 0.05. 
The frequency of each psychiatric disorder was calculated. Next, the mean and frequency 
calculations were completed for the demographic variables of participants within the psychiatric 
group and the control group including ages, sex, proportion of minorities, marital status, and 
education. 
Aim 1. Determine if more than one psychiatric comorbidity is associated with elevated BMI. 
 Independent samples t-tests were used to compare the BMI of participants within the 
control group to participants with each psychiatric disorder. The same process was used to 
compare the BMI of participants in the control group to the BMI of participants with each 
combination of disorders. For example, the BMI of individuals with schizophrenia and social 
phobia was compared to the BMI of the control participants.  
Aim 2. Identify which comorbid mental health conditions are most strongly associated with 
an increased risk for elevated BMI. 
 The number of significant associations among the various psychiatric disorders was 
assessed (see Appendix D). For example, the number of comorbid disorders in addition to bipolar 
disorder was compared to the number of comorbid disorders with generalized anxiety disorder. 
Second, the effect size of these relationships were compared. 
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Aim 3. Determine if the number of psychiatric disorders is associated with elevated BMI. 
A Spearman's Rho correlation was run to examine the relationship between number of 
psychiatric disorders and BMI. Independent samples t-tests were then run comparing the BMI of 
participants with two or more disorders to participants with one disorder. The same process was 
repeated, comparing participants with three or more disorders to participants with participants 




 The potential sample included a total of 20,013 participants. Analyses found 7,355 
individuals with one or more mental illnesses and 12,658 participants with no mental illnesses. 
The sample size and prevalence data for the various disorders is listed in Appendix B. The 
prevalence rates were fairly similar to what has been found in the general US population (Reeves 
et al., 2011). 
 Demographic calculations revealed that individuals in the psychiatric disorders group 
were younger (40.0 years v. 45.3 years, t(23) = 22.94, p <0.001) and less likely to married 
(49.6% v. 56%, 2(1, N = 20,003) = 78.45, p < 0.001). Relative to the control group, the 
psychiatric disorders group had fewer minorities (53.3% v. 60.4%, 2(1, N = 17,910) = 87.87, p < 
0.001), a similar proportion of females (58.1% v. 56.8%, 2(1, N = 20,003) = 2.98, p = 0.084), 
and a similar proportion had studied beyond high school (50.1% v. 50.1%, 2(1, N = 20,013) = 0, 
p = 0.987). 
 Appendix C displays the frequency of the number of disorders among the psychiatric 
disorders group. For example, 3,194 (43.4%) had one disorder, 1,602 (21.8%) had two disorders. 




 Of the 15 disorders examined in this study, six of the disorders, separately, were found to 
be significantly associated with elevated BMI when compared with individuals with no 
psychiatric disorders. These conditions included bipolar disorder, ADHD, post-traumatic stress 
disorder (PTSD), panic disorder, agoraphobia, and separation anxiety disorder. The effect sizes of 
these relationships were relatively small, ranging from 0.20 to 0.26. 
Aim 1. Determine if more than one psychiatric comorbidities is associated with elevated 
BMI. 
 The BMI of participants with each combination of two disorders was compared with 
individuals with no psychiatric disorders, resulting in 132 combinations. Of these, 34 were 
statistically significant with an effect size of d=0.3 or greater. These results were grouped by the 
number of cormorbidities and the effect size associated with these relationships (see Appendices 
3 and 4).  
Aim 2. Identify which comorbid mental health conditions are most strongly associated with 
an increased risk for elevated BMI. 
 The four disorders with the most numerous significant comorbidities associated with 
BMI were bipolar disorder, agoraphobia, attention-deficit hyperactivity disorder, and panic 
disorder (see Appendix E). Bipolar disorder in the presence of eleven other disorders was 
significantly associated with elevated BMI. The mean effect size of these eleven relationships 
was 0.42. Agoraphobia with nine other disorders was associated with BMI with an average effect 
size of 0.44. ADHD comorbid with eight other disorders was linked with higher BMI and an 
average effect size of 0.42. Lastly, panic disorder in the presence of seven other disorders was 
associated with elevated BMI and an average effect size of 0.38. 
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Aim 3. Determine if the number of psychiatric disorders is associated with elevated BMI. 
 A Spearman's Rho correlation showed that the number of psychiatric disorders was not 
associated with BMI (rs = 0.035, p < 0.001). As a result, it appears that individuals with a higher 
number of psychiatric disorders are not necessarily at greater risk for having an elevated BMI. T-
tests revealed that participants with two or more disorders had a BMI that was statistically greater 
than participants with one disorder, but the effect size was negligible (27.8 v. 27.2, t(6,607) = 
3.637, p < 0.001, d=0.09). The same was found regarding participants with three or more 
disorders compared to participants with two or fewer disorders (27.8 v. 27.4, t(4,572) = 2.493, p 
= 0.013, d=0.06). The mean BMI did not differ statistically between participants with four or 
more disorders and participants with three or fewer disorders (27.9 v. 27.7, t(3,852) = 0.986, p 
=0.342, d=0.03). 
Conclusions and Implications 
 This study adds to the understanding of some of the complex relationships that exist 
between mental illness and BMI. Previous studies have established that individuals with a wide 
variety of mental health conditions are at an increased risk for elevated BMI. However, little 
research has examined associations with multiple comorbid psychiatric disorders. 
 Perhaps the most important result uncovered by this research is that no evidence was 
found that most comorbid psychiatric disorders are associated with an increased risk for elevated 
BMI. Rather, a relatively small number of cormorbidities were associated with BMI. The effect 
sizes of the significant associations ranged from d=0.3 to d=0.7. 
 Four disorders were found to have the largest number of comorbid psychiatric disorders 
associated with elevated BMI. Specifically, providers could easily incorporate most of the 
findings by simply remembering that bipolar disorder, agoraphobia, attention-deficit 
hyperactivity disorder, and panic disorder in the presence of most other disorders may put 
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patients at an increased risk for developing obesity. As a result, when such patients are seen, 
height, weight, and BMI should be tracked more closely. In addition, weight management 
interventions such as dietary education and exercise should be focused most intensively on 
patients at the highest risk for obesity. All of the information needed to implement the current 
findings should be produced either through a standard diagnostic interview or a review of the 
existing chart. In most cases, no additional information needs to be obtained from patients. 
 The current study found that only six of the sixteen disorders examined were associated 
with elevated BMI by themselves. Furthermore, the effect sizes of these associations were 
relatively small (d=0.2-0.26). By contrast, 34 combinations of disorders were associated with a 
significant risk for elevated BMI with an effect size of at least 0.3. 
 There were a number of limitations in this study. Some of the limitations originated from 
the fact that the participants did not fit within mutually exclusive groups. For example, an 
individual could have bipolar disorder, generalized anxiety disorder, and an alcohol use disorder. 
As a result, statistical methods such as ANOVAs could not be used to compare BMIs between 
individuals with various psychiatric diagnoses. Establishing mutually exclusive groups that 
include specific disorders while excluding others may be a viable approach for future research, 
but would not have been feasible for the current study as it would require hundreds of 
calculations. 
 It is acknowledged that t-tests and Spearman correlations are rather basic statistical tools. 
However, two factors prevented the use of more sophisticated techniques such as regression 
models capable of factoring in the impact of variables such as sex, age, and others. First, the data 
set itself has a significant number of gaps in which certain participants were asked some groups 
of questions whereas others were not. Second, the large number of groups established in this 
research would require the development of hundreds of regression models. Even limiting the 
models to the 34 relationships found to be significant would be cumbersome and limited due to 
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gaps in the data set. Unfortunately, the current results cannot be compared with previous research 
as this is the first analysis of comorbid psychiatric disorders and BMI. 
 The current research did have a number of strengths. First, the extensive randomization in 
the selection of subjects produced a sample which is likely representative of members of the 
general public. Because controls were selected from the same population using the same methods 
as participants in the psychiatric disorders group, we can have a high degree of confidence in 
their comparisons. Second, due to the comprehensive nature of the surveys, we were able to 
examine the combinations of most psychiatric disorders. Third, the overall survey included a very 
large number of questions so it is very unlikely that the participants systematically altered their 
responses based on perceived researcher expectations. 
 Future research could focus more on the disorders that were found to be associated with 
an elevated BMI in this study. An examination fewer groups would allow for a more detailed 
examination of a larger number of variables. Specifically, sex, age, dietary factors, and exercise 
habits could be analyzed in this population. 
 The current study provides some guidance to medical professionals in helping their 
patients to maintain a healthy weight. Patients with multiple comorbid psychiatric disorders 
should be monitored more closely and considered for more intensive weight management 
interventions. In particular, patients who have agoraphobia, bipolar disorder, panic disorder, or 
ADHD in addition to at least one other disorder should be receive special attention in this area. 
This is not to say that the current study provides evidence to support the relaxed monitoring of 
patients with other disorders as the sample sizes were often too small to determine if a significant 
relationship exists. Obesity remains a significant challenge for psychiatric patients and their 
providers. We can start to control this epidemic by identifying people at greatest risk, offering 
weight management interventions, and by remaining vigilant in monitoring for weight gain. 
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Proposed Conceptual Model 
 
  





Diagnosis n prevalence 
Schizophrenia 181 0.9 
Major depressive disorder 3,241 13.1 
Bipolar disorder 299 1.5 
Alcohol use disorders 1,725 8.6 
Drug use disorders 1,087 5.4 
Conduct disorder 2,491 10.6 
Intermittent explosive disorder 975 4.9 
Oppositional defiant disorder 689 3.4 
Attention deficit hyperactivity disorder 518 5 
Generalized anxiety disorder 1,220 6.1 
Panic disorder 4,635 4.1 
Separation anxiety 552 2.8 
Social phobia 1,909 8 
Agoraphobia 495 2.5 
Specific phobia 1,198 6 
Post-traumatic stress disorder 1,194 6 
 
Prevalence of Psychiatric Disorders in Sample 
  








1 3,194 43.4 
2 1,602 21.8 
3 1,005 13.7 
4 604 8.2 
5 395 5.4 
6 237 3.2 
7 149 2 
 
Prevalence of the Number of Comorbid Disorders in the Psychiatric Disorders Group 
  





Disorder Number of significant 
comorbidities 
Average effect size 
Bipolar disorder 11 0.424 
Agoraphobia 9 0.444 
ADHD 8 0.424 
Panic disorder 7 0.383 
PTSD 5 0.388 
Separation anxiety 5 0.418 
Social phobia 4 0.358 
GAD 4 0.345 
Specific phobia 4 0.338 
MDD 3 0.323 
Drug use disorder 3 0.31 
IED 2 0.35 
ODD 1 0.5 
Conduct disorder 1 0.32 
 
Number of Comorbidities and Average Effect Size 
  





Agoraphobia Bipolar disorder 0.72 Bipolar 
disorder 
Agoraphobia 0.72 
 ADHD 0.60  ADHD 0.55 
 ODD 0.50  PTSD 0.46 
 Separation anxiety 0.48  Separation 
anxiety 
0.42 
 Panic disorder 0.37  Social phobia 0.39 
 Major depressive 
disorder 
0.35  IED 0.38 
 GAD 0.35  Panic disorder 0.38 
 IED 0.32  GAD 0.36 
 Drug 0.31  Drug use 
disorder 
0.36 





ADHD 0.52 ADHD Agoraphobia 0.6 
 Separation anxiety 0.43  Bipolar disorder 0.55 
 Bipolar disorder 0.38  Panic disorder 0.52 
 Social phobia 0.37  PTSD 0.46 
 Agoraphobia 0.37  Specific Phobia 0.38 
 Specific phobia 0.31  Separation 
anxiety 
0.37 
 Major depressive 
disorder 
0.3  GAD 0.36 
    Social phobia 0.35 





Disorders with the Greatest Number of Significant Comorbid Disorders and their Effect Sizes 
